Medical News Today: Novel Alzheimer’s drug passes first phase of human testing

A drug that tackles toxic protein buildup in Alzheimer’s disease in a novel way has passed phase 1 of clinical trials, which tests safety in humans.

Leave a Reply

Your email address will not be published. Required fields are marked *